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Introduction and aims: Considerable differences in prevalence and mortality rates from COVID-19, 
with higher rates among European countries and Iran versus African and Asian countries in part due 
to early and extensive prevention measures. There has been considerable controversy surrounding 
hydroxychloroquine, with resultant misinformation increasing prices and suicides. Growing concerns 
also with unintended consequences of lockdown and other measures. Consequently, a need to 
investigate changes in utilisation and prices of relevant medicines during the pandemic in Namibia 
with its proactive approach to guide future decision making. Community pharmacists play a key role in 
this respect. Methods: Questionnaire survey among 55 pharmacists from March to end June 2020. 
Results: Proactivity among some pharmacists to plan for the pandemic with increased stocks. Limited 
increases in utilisation of antimalarials and antibiotics in Namibia versus other countries enhanced by 
restrictions on self-purchasing in Namibia, reflected in limited price rises and shortages. Higher use of 
Vitamin C/ immune boosters in Ghana and Nigeria versus Namibia reflected in higher price rises, with 
increased utilisation and prices of PPE across all countries. Encouragingly lower increases in herbal 
medicines in Namibia versus Ghana. Concerns though with unintended consequences. Conclusion: 
Encouraging to see continued low prevalence and mortality rates from COVID-19 in Namibia and 
limited increase in utilisation of antimalarials and antibiotics with prescribing restrictions. Concerns 
with rising rates of malaria and other infectious diseases following lockdown need addressing. 
Pharmacists can help plan for the future, educate the public during pandemics, help with vaccinations 
and general medicines management.   
 
